Home/Filings/4/0001415889-25-022294
4//SEC Filing

Kapadia Sandip 4

Accession 0001415889-25-022294

CIK 0001802665other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:15 PM ET

Size

5.3 KB

Accession

0001415889-25-022294

Insider Transaction Report

Form 4
Period: 2025-08-15
Kapadia Sandip
CHIEF FINANCIAL OFFICER
Transactions
  • Sale

    Common Stock

    2025-08-15$36.50/sh21,573$787,3780 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.11 to $36.87. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Harmony Biosciences Holdings, Inc.

CIK 0001802665

Entity typeother

Related Parties

1
  • filerCIK 0001677141

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:15 PM ET
Size
5.3 KB